Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionCNB Bank
Latest Disclosed Ownership836 shares
Latest Disclosed Value $ 294,147
CNB Bank ownership in AMGN / Amgen Inc.

On May 6, 2026 - CNB Bank filed a 13F-HR form disclosing ownership of 836 shares of Amgen Inc. (MX:AMGN) valued at $294,147 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 836 shares of Amgen Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F AMGEN COM 031162100 836 0 0.00 294 7.69 0.1238
2026-02-11 2025-12-31 13F AMGEN COM 031162100 836 -20 -2.34 274 13.28 0.1120
2025-10-30 2025-09-30 13F AMGEN COM 031162100 856 -50 -5.52 242 -4.37 0.1006
2025-07-31 2025-06-30 13F AMGEN COM 031162100 906 -118 -11.52 253 -21.00 0.1199
2025-04-24 2025-03-31 13F AMGEN COM 031162100 1,024 -330 -24.37 319 -9.37 0.1615
2025-01-15 2024-12-31 13F Amgen COM 031162100 1,354 -12 -0.88 353 -20.00 0.1640
2024-10-18 2024-09-30 13F Amgen COM 031162100 1,366 -5 -0.36 440 2.80 0.2036
2024-08-08 2024-06-30 13F Amgen COM 031162100 1,371 -17 -1.22 428 8.63 0.2061
2024-05-02 2024-03-31 13F Amgen COM 031162100 1,388 -5 -0.36 395 -1.75 0.1924
2024-01-31 2023-12-31 13F Amgen COM 031162100 1,393 -56 -3.86 401 3.08 0.2154
2023-11-02 2023-09-30 13F Amgen COM 031162100 1,449 -185 -11.32 389 7.46 0.2293
2023-08-08 2023-06-30 13F Amgen COM 031162100 1,634 384 30.72 363 19.87 0.2134
2023-05-10 2023-03-31 13F Amgen COM 031162100 1,250 -54 -4.14 302 -11.70 0.1839
2023-02-13 2022-12-31 13F Amgen COM 031162100 1,304 -127 -8.87 342 5.88 0.2141
2022-11-14 2022-09-30 13F Amgen COM 031162100 1,431 -409 -22.23 323 -27.90 0.2185
2022-08-19 2022-06-30 13F/A-1 Amgen COM 031162100 1,840 -3,347 -64.53 448 -64.27 0.2898
2022-08-10 2022-06-30 13F Amgen COM 031162100 2,389 -2,798 582 0.2400
2022-04-13 2022-03-31 13F Amgen COM 031162100 5,187 520 11.14 1,254 19.43 0.6951
2022-01-31 2021-12-31 13F Amgen COM 031162100 4,667 90 1.97 1,050 7.91 0.5753
2021-11-02 2021-09-30 13F Amgen COM 031162100 4,577 427 10.29 973 -3.85 0.5844
2021-07-29 2021-06-30 13F Amgen COM 031162100 4,150 -85 -2.01 1,012 -3.98 0.6329
2021-05-03 2021-03-31 13F Amgen COM 031162100 4,235 -919 -17.83 1,054 -11.05 0.7292
2021-01-27 2020-12-31 13F Amgen COM 031162100 5,154 -20 -0.39 1,185 -9.89 0.8950
2020-10-26 2020-09-30 13F Amgen COM 031162100 5,174 214 4.31 1,315 12.39 1.1069
2020-07-14 2020-06-30 13F Amgen COM 031162100 4,960 117 2.42 1,170 19.14 1.0297
2020-05-13 2020-03-31 13F Amgen COM 031162100 4,843 1,352 38.73 982 16.63 1.0578
2020-01-27 2019-12-31 13F Amgen COM 031162100 3,491 621 21.64 842 51.71 0.7128
2019-11-04 2019-09-30 13F Amgen COM 031162100 2,870 1,286 81.19 555 90.07 0.5137
2019-08-14 2019-06-30 13F Amgen COM 031162100 1,584 1,413 826.32 292 784.85 0.2492
2019-04-29 2019-03-31 13F Amgen Inc Com COM 031162100 171 51 42.50 33 43.48 0.0170
2019-02-06 2018-12-31 13F Amgen Inc Com COM 031162100 120 0 0.00 23 -8.00 0.0147
2018-11-13 2018-09-30 13F Amgen Inc Com COM 031162100 120 0 0.00 25 13.64 0.0143
2018-08-14 2018-06-30 13F Amgen Inc Com COM 031162100 120 35 41.18 22 46.67 0.0128
2018-05-11 2018-03-31 13F Amgen Inc Com COM 031162100 85 -50 -37.04 15 -34.78 0.0088
2018-02-20 2017-12-31 13F Amgen Inc Com COM 031162100 135 135 23 0.0138
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.